614 related articles for article (PubMed ID: 18084158)
41. Endocrinopathies in patients with thalassemias.
Al-Elq AH; Al-Saeed HH
Saudi Med J; 2004 Oct; 25(10):1347-51. PubMed ID: 15494799
[TBL] [Abstract][Full Text] [Related]
42. Osteoporosis in beta-thalassemia: Clinical and genetic aspects.
Origa R; Fiumana E; Gamberini MR; Armari S; Mottes M; Sangalli A; Paglietti E; Galanello R; Borgna-Pignatti C
Ann N Y Acad Sci; 2005; 1054():451-6. PubMed ID: 16339696
[TBL] [Abstract][Full Text] [Related]
43. Endocrine gland abnormalities in thalassemia major: a brief review.
Mohammadian S; Bazrafshan HR; Sadeghi-Nejad A
J Pediatr Endocrinol Metab; 2003 Sep; 16(7):957-64. PubMed ID: 14513870
[TBL] [Abstract][Full Text] [Related]
44. Cardiomyopathy and pericardial effusion in a 7 year-old boy with beta-thalassaemia major, severe primary hypothyroidism and hypoparathyroidism due to iron overload.
De Sanctis V; Govoni MR; Sprocati M; Marsella M; Conti E
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():181-4. PubMed ID: 19337175
[TBL] [Abstract][Full Text] [Related]
45. Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.
Albu A; Barbu CG; Antonie L; Vladareanu F; Fica S
Postgrad Med; 2014 Sep; 126(5):121-7. PubMed ID: 25295656
[TBL] [Abstract][Full Text] [Related]
46. Primary hypothyroidism and multiple endocrine failure in association with hemochromatosis in a long-term hemodialysis patient.
Shirota T; Shinoda T; Aizawa T; Mizukami T; Katakura M; Takasu N; Yamada T
Clin Nephrol; 1992 Aug; 38(2):105-9. PubMed ID: 1516278
[TBL] [Abstract][Full Text] [Related]
47. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U
Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012
[TBL] [Abstract][Full Text] [Related]
48. Clinical utility of endocrine markers predicting myocardial siderosis in transfusion dependent thalassemia major.
Ehsan L; Rashid M; Alvi N; Awais K; Nadeem O; Asghar A; Sajjad F; Fatima M; Qidwai A; Hussain S; Hasan E; Brown N; Altaf S; Hasan B; Kirmani S
Pediatr Blood Cancer; 2018 Oct; 65(10):e27285. PubMed ID: 29893484
[TBL] [Abstract][Full Text] [Related]
49. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
[TBL] [Abstract][Full Text] [Related]
50. Multiple Pathological Fractures Secondary to Endocrinopathy from Thalassaemia.
Ho SW; Kwek EB
Ann Acad Med Singap; 2016 Jul; 45(7):318-21. PubMed ID: 27523513
[No Abstract] [Full Text] [Related]
51. A study on endocrine dysfunction in thalassaemia.
Ghosh S; Bandyopadhyay SK; Bandyopadhyay R; Roy D; Maisnam I; Ghosh MK
J Indian Med Assoc; 2008 Oct; 106(10):655-6, 658-9. PubMed ID: 19552099
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.
Belhoul KM; Bakir ML; Kadhim AM; Dewedar HE; Eldin MS; Alkhaja FA
Ann Saudi Med; 2013; 33(1):18-21. PubMed ID: 23458935
[TBL] [Abstract][Full Text] [Related]
53. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia.
De Sanctis V; Roos M; Gasser T; Fortini M; Raiola G; Galati MC;
J Pediatr Endocrinol Metab; 2006 Apr; 19(4):471-80. PubMed ID: 16759032
[TBL] [Abstract][Full Text] [Related]
54. Growth and sexual maturation in children with thalassemia major.
Yesilipek MA; Bircan I; Oygür N; Ertug H; Yegin O; Güven AG
Haematologica; 1993; 78(1):30-3. PubMed ID: 8491419
[TBL] [Abstract][Full Text] [Related]
55. Endocrine histology findings in a prepubertal thalassemic girl with multiple endocrine complications secondary to iron overload.
De Sanctis V; Giovannini M
Georgian Med News; 2011 Apr; (193):51-5. PubMed ID: 21617275
[TBL] [Abstract][Full Text] [Related]
56. Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment.
De Sanctis V; Soliman AT; Elsedfy H; Yassin M; Canatan D; Kilinc Y; Sobti P; Skordis N; Karimi M; Raiola G; Galati MC; Bedair E; Fiscina B; El Kholy M;
Pediatr Endocrinol Rev; 2013 Dec; 11(2):167-80. PubMed ID: 24575552
[TBL] [Abstract][Full Text] [Related]
57. Successful pregnancy after bone marrow transplantation for thalassaemia.
Borgna-Pignatti C; Marradi P; Rugolotto S; Marcolongo A
Bone Marrow Transplant; 1996 Jul; 18(1):235-6. PubMed ID: 8832025
[TBL] [Abstract][Full Text] [Related]
58. Complications of thalassemia major and their treatment.
Borgna-Pignatti C; Gamberini MR
Expert Rev Hematol; 2011 Jun; 4(3):353-66. PubMed ID: 21668399
[TBL] [Abstract][Full Text] [Related]
59. Sex steroid priming for induction of puberty in thalassemia patients with pulsatile reversible hypogonadotrophic hypogonadism.
Chatterjee R; Mukhopadhyay TN; Chandra S; Bajoria R
Hemoglobin; 2011; 35(5-6):659-64. PubMed ID: 22074126
[TBL] [Abstract][Full Text] [Related]
60. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.
Roth C; Pekrun A; Bartz M; Jarry H; Eber S; Lakomek M; Schröter W
Eur J Pediatr; 1997 Oct; 156(10):777-83. PubMed ID: 9365067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
